Pablo Ryan at Instituto de Investigación Sanitaria Gregorio Marañón - Research Interests, Publications & Academic Profile

Pablo Ryan

Instituto de Investigación Sanitaria Gregorio Marañón

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Continue in dashboard

Contact this professor

ORCID

Google Scholar

Research Interests

Virology

100%

Epidemiology

60%

Covid-19

100%

Sars-cov-2

90%

Hiv

50%

Antiviral Therapy

40%

Hepatitis C

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles20

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

Article Link

Year:

2024

Post-COVID-19 Pain Is Not Associated with DNA Methylation Levels of the ACE2 Promoter in COVID-19 Survivors Hospitalized Due to SARS-CoV-2 Infection

Article Link

Year:

2024

DNA Methylation Levels of the ACE2 Promoter Are Not Associated with Post-COVID-19 Symptoms in Individuals Who Had Been Hospitalized Due to COVID-19

Article Link

Year:

2024

Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?

Article Link

Year:

2024

Inflammatory Polymorphisms (IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors

Article Link

Year:

2024

Inflammatory Polymorphisms (IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors

Article Link

Year:

2024

HLA-A11:01 and HLA-C04:01 are associated with severe COVID-19

Article Link

Year:

2023

A second update on mapping the human genetic architecture of COVID-19

Article Link

Year:

2023

Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain

Article Link

Year:

2023

Diagnostic Performance of the HCV Core Antigen Test To Identify Hepatitis C in HIV-Infected Patients: a Systematic Review and Meta-Analysis

Article Link

Year:

2023

Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study

Article Link

Year:

2022

Dynamics of HIV Reservoir and HIV-1 Viral Splicing in HCV-Exposed Individuals after Elimination with DAAs or Spontaneous Clearance

Article Link

Year:

2022

A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid

Article Link

Year:

2022

Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D

Article Link

Year:

2022

Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care

Article Link

Year:

2022

Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817)

Article Link

Year:

2022

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

Article Link

Year:

2022

HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization

Article Link

Year:

2022

Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort

Article Link

Year:

2022

Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation

Article Link

Year:

2022

Collaborators3

Verónica Briz

Head of HIV and viral hepatitis coinfection group (COVIHEP)

Institute of Health Carlos III

SPAIN

View Details

Carlos Rodríguez-Gallego

Associated Professor

Universidad Fernando Pessoa Canarias

SPAIN

View Details

Claudia Palladino

Universidade de Lisboa Faculdade de Farmácia

PORTUGAL

View Details

How do I reach out?

Continue in dashboard

Pablo Ryan

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles20

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

Post-COVID-19 Pain Is Not Associated with DNA Methylation Levels of the <i>ACE2</i> Promoter in COVID-19 Survivors Hospitalized Due to SARS-CoV-2 Infection

DNA Methylation Levels of the ACE2 Promoter Are Not Associated with Post-COVID-19 Symptoms in Individuals Who Had Been Hospitalized Due to COVID-19

Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?

Inflammatory Polymorphisms (IL-6 <i>rs1800796</i>, IL-10 <i>rs1800896</i>, TNF-α <i>rs1800629</i>, and IFITM3 <i>rs12252</i>) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors

Inflammatory Polymorphisms (IL-6 <i>rs1800796</i>, IL-10 <i>rs1800896</i>, TNF-α <i>rs1800629</i>, and IFITM3 <i>rs12252</i>) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors

<i>HLA-A11:01</i> and <i>HLA-C04:01</i> are associated with severe COVID-19

A second update on mapping the human genetic architecture of COVID-19

Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain

Diagnostic Performance of the HCV Core Antigen Test To Identify Hepatitis C in HIV-Infected Patients: a Systematic Review and Meta-Analysis

Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study

Dynamics of HIV Reservoir and HIV-1 Viral Splicing in HCV-Exposed Individuals after Elimination with DAAs or Spontaneous Clearance

A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid

Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D

Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care

Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817)

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization

Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort

Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation

Collaborators3

Verónica Briz

Carlos Rodríguez-Gallego

Claudia Palladino

How do I reach out?